It's trying to bring back the woolly mammoth — and it just got $200 millionByBruce GilPublishedJanuary 15, 2025
Office vacancies hit a new high in 2024 despite return-to-office pushByBruce GilPublishedJanuary 10, 2025
Trump's Ozempic tariffs, Zepbound on Medicare, and rising drug prices: Pharma news roundupByBruce GilPublishedJanuary 10, 2025
This free tool uses AI to appeal insurance denials — which may have been denied by AIByBruce GilPublishedJanuary 9, 2025
FTC Chair Lina Khan hopes Trump admin won't strike 'sweetheart' deals with Amazon and MetaByBruce GilPublishedJanuary 7, 2025
Google's anti-aging company just released 'disappointing' drug trial resultsByBruce GilPublishedJanuary 7, 2025
Disney found a way to kill a lawsuit stalling its new venture: It bought the streamer that was suing itByBruce GilPublishedJanuary 6, 2025
The 7 biggest health insurance companies that control almost 75% of the marketByBruce GilUpdatedJanuary 6, 2025
The US is spending $306 million to combat the spread of the bird fluByBruce GilPublishedJanuary 3, 2025
Broccoli sold in Walmarts across the U.S. is recalled over listeria concernsByBruce GilPublishedJanuary 3, 2025
Results are in for a new depression drug trial, and they're cratering this stockByBruce GilPublishedJanuary 2, 2025
